Comparison of artesunate–mefloquine and artemether–lumefantrine fixed-dose combinations for treatment of uncomplicated Plasmodium falciparum malaria in children younger than 5 years in sub-Saharan Africa: a randomised, multicentre, phase 4 trial
Open Access
- 1 October 2016
- journal article
- research article
- Published by Elsevier in The Lancet Infectious Diseases
- Vol. 16 (10) , 1123-1133
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Spread of Artemisinin Resistance in Plasmodium falciparum MalariaNew England Journal of Medicine, 2014
- MalariaThe Lancet, 2014
- Effect of artesunate-mefloquine fixed-dose combination in malaria transmission in amazon basin communitiesMalaria Journal, 2012
- How artemisinin-containing combination therapies slow the spread of antimalarial drug resistanceTrends in Parasitology, 2010
- Effectiveness of five artemisinin combination regimens with or without primaquine in uncomplicated falciparum malaria: an open-label randomised trialThe Lancet Infectious Diseases, 2010
- The neurological assessment in young children treated with artesunate monotherapy or artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malariaMalaria Journal, 2009
- Efficacy and tolerability of four antimalarial combinations in the treatment of uncomplicated Plasmodium falciparum malaria in SenegalMalaria Journal, 2007
- An open label randomized comparison of mefloquine–artesunate as separate tablets vs. a new co‐formulated combination for the treatment of uncomplicated multidrug‐resistant falciparum malaria in ThailandTropical Medicine & International Health, 2006
- Clinical Pharmacokinetics of MefloquineClinical Pharmacokinetics, 1990
- MEFLOQUINE THERAPY FOR PLASMODIUM-FALCIPARUM MALARIA IN CHILDREN UNDER 5 YEARS OF AGE IN MALAWI - INVIVO INVITRO EFFICACY AND CORRELATION OF DRUG CONCENTRATION WITH PARASITOLOGICAL OUTCOME1990